V. Fanotto

1.6k total citations
32 papers, 868 citations indexed

About

V. Fanotto is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, V. Fanotto has authored 32 papers receiving a total of 868 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Oncology, 12 papers in Cancer Research and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in V. Fanotto's work include Cancer Treatment and Pharmacology (7 papers), Breast Cancer Treatment Studies (7 papers) and Gastric Cancer Management and Outcomes (7 papers). V. Fanotto is often cited by papers focused on Cancer Treatment and Pharmacology (7 papers), Breast Cancer Treatment Studies (7 papers) and Gastric Cancer Management and Outcomes (7 papers). V. Fanotto collaborates with scholars based in Italy, United States and Malaysia. V. Fanotto's co-authors include Fabio Puglisi, Lorenzo Gerratana, Giuseppe Aprile, Debora Basile, Marta Bonotto, Gianpiero Fasola, M. Cinausero, Paola Ermacora, Alessandro Marco Minisini and Silvia Bolzonello and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and British Journal of Cancer.

In The Last Decade

V. Fanotto

32 papers receiving 857 citations

Peers

V. Fanotto

ONCOL

PRM

SURGE

Tetsuhiko Taira Japan

Enzo Maria Ruggeri Italy

Metin Özkan Türkiye

Jesús Romero Spain

Yaping Xu China

Qiuhua Deng China

Nuttapong Ngamphaiboon Thailand

Vladmir Cláudio Cordeiro de Lima Brazil

Marco Mazzotta Italy

Timothée Olivier Switzerland

Tetsuhiko Taira Japan

V. Fanotto

589 ×1.2

ONCOL

636 ×1.6

PRM

203 ×1.1

188 ×1.1

84 ×0.8

SURGE

Citations per year, relative to V. Fanotto V. Fanotto (= 1×) peers Tetsuhiko Taira

Countries citing papers authored by V. Fanotto

Since Specialization

Citations

This map shows the geographic impact of V. Fanotto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V. Fanotto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V. Fanotto more than expected).

Fields of papers citing papers by V. Fanotto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by V. Fanotto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V. Fanotto. The network helps show where V. Fanotto may publish in the future.

Co-authorship network of co-authors of V. Fanotto

This figure shows the co-authorship network connecting the top 25 collaborators of V. Fanotto. A scholar is included among the top collaborators of V. Fanotto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with V. Fanotto. V. Fanotto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Fanotto, V., Daniele Rossini, Mariaelena Casagrande, et al.. (2023). Primary Tumor Resection in Synchronous Metastatic Colorectal Cancer Patients Treated with Upfront Chemotherapy plus Bevacizumab: A Pooled Analysis of TRIBE and TRIBE2 Studies. Cancers. 15(22). 5451–5451. 1 indexed citations

Moretto, Roberto, Marco Maria Germani, Mirella Giordano, et al.. (2023). Trop-2 and Nectin-4 immunohistochemical expression in metastatic colorectal cancer: searching for the right population for drugs’ development. British Journal of Cancer. 128(7). 1391–1399. 14 indexed citations

Nardo, Paola Di, Silvio Ken Garattini, V. Fanotto, et al.. (2022). Systemic Treatments for Advanced Small Bowel Adenocarcinoma: A Systematic Review. Cancers. 14(6). 1502–1502. 6 indexed citations

Posocco, Bianca, Michela Guardascione, Luisa Foltran, et al.. (2021). A rapid, simple and sensitive LC-MS/MS method for lenvatinib quantification in human plasma for therapeutic drug monitoring. PLoS ONE. 16(10). e0259137–e0259137. 10 indexed citations

Re, Vallì De, Laura Caggiari, Mariangela De Zorzi, et al.. (2020). Epstein-Barr virus BART microRNAs in EBV- associated Hodgkin lymphoma and gastric cancer. Infectious Agents and Cancer. 15(1). 42–42. 42 indexed citations

Salati, Massimiliano, Giulia Orsi, Giordano Beretta, et al.. (2019). Gastric cancer: Translating novels concepts into clinical practice. Cancer Treatment Reviews. 79. 101889–101889. 58 indexed citations

Pelizzari, Giacomo, Lorenzo Gerratana, Debora Basile, et al.. (2018). Post-neoadjuvant strategies in breast cancer: From risk assessment to treatment escalation. Cancer Treatment Reviews. 72. 7–14. 21 indexed citations

Bonotto, Marta, Debora Basile, Lorenzo Gerratana, et al.. (2018). Controversies in monitoring metastatic breast cancer during systemic treatment. Results of a GIM (Gruppo Italiano Mammella) survey. The Breast. 40. 45–52. 6 indexed citations

Garattini, Silvio Ken, Debora Basile, Monica Cattaneo, et al.. (2017). Molecular classifications of gastric cancers: Novel insights and possible future applications. World Journal of Gastrointestinal Oncology. 9(5). 194–194. 45 indexed citations

10.

Bonotto, Marta, Silvio Ken Garattini, Debora Basile, et al.. (2017). Immunotherapy for gastric cancers: emerging role and future perspectives. Expert Review of Clinical Pharmacology. 10(6). 609–619. 30 indexed citations

11.

Cinausero, M., Giuseppe Aprile, Paola Ermacora, et al.. (2017). New Frontiers in the Pathobiology and Treatment of Cancer Regimen-Related Mucosal Injury. Frontiers in Pharmacology. 8. 354–354. 189 indexed citations

12.

Ongaro, Elena, M. Cinausero, Riccardo Caccialanza, et al.. (2017). Sarcopenia in gastric cancer: when the loss costs too much. Gastric Cancer. 20(4). 563–572. 51 indexed citations

13.

Gerratana, Lorenzo, Marta Bonotto, Elena Ongaro, et al.. (2017). Pertuzumab and breast cancer: another piece in the anti-HER2 puzzle. Expert Opinion on Biological Therapy. 17(3). 365–374. 27 indexed citations

14.

Cinausero, M., Lorenzo Gerratana, Elisa De Carlo, et al.. (2017). Determinants of Last-line Treatment in Metastatic Breast Cancer. Clinical Breast Cancer. 18(3). 205–213. 9 indexed citations

15.

Fanotto, V., Elena Ongaro, Karim Rihawi, et al.. (2016). HER-2 inhibition in gastric and colorectal cancers: tangible achievements, novel acquisitions and future perspectives. Oncotarget. 7(42). 69060–69074. 26 indexed citations

16.

Gerratana, Lorenzo, V. Fanotto, Giacomo Pelizzari, Elisa Agostinetto, & Fabio Puglisi. (2016). Do platinum salts fit all triple negative breast cancers?. Cancer Treatment Reviews. 48. 34–41. 44 indexed citations

17.

Gerratana, Lorenzo, V. Fanotto, Marta Bonotto, et al.. (2015). Pattern of metastasis and outcome in patients with breast cancer. Clinical & Experimental Metastasis. 32(2). 125–133. 161 indexed citations

18.

Fanotto, V., Caterina Fontanella, Mario Uccello, et al.. (2015). Impact of age, ECOG PS and type of treatment on progression-free survival and overall survival in second-line therapy for advanced gastric cancer: analysis on 709 cases. Annals of Oncology. 26. vi91–vi91. 1 indexed citations

19.

Fontanella, Caterina, V. Fanotto, Karim Rihawi, Giuseppe Aprile, & Fabio Puglisi. (2015). Skeletal metastases from breast cancer: pathogenesis of bone tropism and treatment strategy. Clinical & Experimental Metastasis. 32(8). 819–833. 26 indexed citations

20.

Gerratana, Lorenzo, V. Fanotto, Marta Bonotto, et al.. (2014). Pattern of metastatic spread and prognosis of breast cancer biologic subtypes.. Journal of Clinical Oncology. 32(15_suppl). e12532–e12532. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact